Jose Luis
Alonso Romero
Asociado Ciencias de la Salud
Hospital Clinico Universitario de Valencia
Valencia, EspañaPublications en collaboration avec des chercheurs de Hospital Clinico Universitario de Valencia (3)
2024
2022
2021
-
Pembrolizumab plus eribulin in hormone-receptor–positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trial
European Journal of Cancer, Vol. 148, pp. 382-394